M&T Bank
SAGE icon

M&T Bank’s Sage Therapeutics SAGE Stock Holding History

M&T Bank’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,096
Closed -$294K – 1602
2019
Q3 		$294K Sell
2,096
-1,283
-38% -$215K ﹤0.01% 1215
2019
Q2 		$620K Buy
3,379
+50
+2% +$8.53K ﹤0.01% 894
2019
Q1 		$529K Buy
3,329
+1,001
+43% +$145K ﹤0.01% 930
2018
Q4 		$223K Buy
2,328
+890
+62% +$102K ﹤0.01% 1249
2018
Q3 		$203K Buy
1,438
+303
+27% +$46.8K ﹤0.01% 1430
2018
Q2 		$178K Buy
+1,135
New +$178K ﹤0.01% 1447
2016
Q1 		– Sell
-4,789
Closed -$279K – 1795
2015
Q4 		$279K Buy
+4,789
New +$237K ﹤0.01% 1331

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

M&T Bank's SAGE Position: Q4 2019 in Review

M&T Bank sold out of Sage Therapeutics (SAGE) in Q4 2019, closing a stake of 2,096 shares — an estimated $294K sold.

M&T Bank first reported a position in SAGE in Q4 2015 and held it in 7 quarters. The position peaked at $620K in Q2 2019. 267 funds tracked by Wall St. Rank hold SAGE as of Q4 2019.

  • M&T Bank reported no remaining Sage Therapeutics position as of Q4 2019 after selling out during the quarter.
  • M&T Bank sold 2,096 Sage Therapeutics shares in Q4 2019, an estimated $294K.
  • M&T Bank first reported a position in Sage Therapeutics in Q4 2015 and held it in 7 quarters.
  • M&T Bank's Sage Therapeutics position peaked at $620K in Q2 2019.
  • 267 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2019.

Based on M&T Bank's 13F filing for Q4 2019, filed 7 Feb 2020.